Aeroallergens from trees, grasses, mold, dust, and others can produce symptoms that range from minor to severe in affected individuals. Our 20 Inhalant IgE Panel assesses antibody response to 20 airborne allergens, providing helpful information for effective allergy management.
US BioTek runs all IgE panels on a sophisticated FDA-approved immunoassay analyzer that utilizes enzyme-amplified chemiluminescence technology. Chemiluminescence provides lower detection limits than conventional ELISA, making it particularly suitable for IgE detection, which can be hard to detect due to its short half-life compared to other immunoglobulins.
Results illustrate reactivity to each antigen, reported in five zones from No Reaction to Extremely High Reaction.